Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SC0062 in proteinuric chronic kidney disease
CTR20230689Phase 2Completed
- Sponsor
- Zhikang Hongyi
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SC0062 in diabetic glomerulosclerosis, IgA nephropathy (IgAN), chronic kidney disease (CKD), sponsored by Zhikang Hongyi. Started Jun 2023; status: completed.
02
Drugs
SC0062
03
Conditions
diabetic glomerulosclerosisIgA nephropathy (IgAN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20230689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230689.